Editorial Board

doi : 10.1016/S0161-6420(21)00947-7

Volume 129, Issue 3, March 2022, Page A3

Buy The Package and View The Article Online

Contents

doi : 10.1016/S0161-6420(21)00948-9

Buy The Package and View The Article Online

This Issue at a Glance

SandeepRavindranPhD

doi : 10.1016/j.ophtha.2022.01.004

Buy The Package and View The Article Online

A Simple Vista en Este Número

SandeepRavindranPhD

doi : 10.1016/j.ophtha.2022.01.013

Buy The Package and View The Article Online

期刊一览

SandeepRavindranPhD

doi : 10.1016/j.ophtha.2022.01.014

Buy The Package and View The Article Online

Abstracts

doi : 10.1016/j.ophtha.2022.01.011

Buy The Package and View The Article Online

Abstracts

doi : 10.1016/j.ophtha.2022.01.010

Buy The Package and View The Article Online

Science Matters

Stephen D.McLeodMD

doi : 10.1016/j.ophtha.2022.01.022

Buy The Package and View The Article Online

Endophthalmitis Rates among Medicare Beneficiaries Undergoing Cataract Surgery between 2011 and 2019

SidraZafarMD1ChenDunMHS2DivyaSrikumaranMD1PeiqiWangMD, MPH2Oliver D.ScheinMD, MPH1MartinMakaryMD, MPH23FasikaWoretaMD, MPH1

doi : 10.1016/j.ophtha.2021.09.004

Buy The Package and View The Article Online

The Impact of the Coronavirus Disease 2019 Pandemic on Adherence to Ocular Hypotensive Medication in Patients with Primary Open-Angle Glaucoma

LyneRacettePhD1Sampson ListowellAbuOD1ShervonnePoleonBSc2TracyThomasBSc1NouranSabbaghMD3Christopher A.GirkinMD, MSPH1

doi : 10.1016/j.ophtha.2021.10.009

Buy The Package and View The Article Online

Ocular Biometric Risk Factors for Progression of Primary Angle Closure Disease: The Zhongshan Angle Closure Prevention Trial

Benjamin Y.XuMD, PhD1David S.FriedmanMD, PhD2Paul J.FosterPhD, FRCS(Ed)3YuJiangMD4NataliaPorporatoMD5Anmol A.PardeshiMS1YuzhenJiangMD, PhD4BeatrizMunozMS6TinAungPhD, FRCS(Ed)5MingguangHeMD, PhD4

doi : 10.1016/j.ophtha.2021.10.003

Buy The Package and View The Article Online

Extraocular Extension of a Regressed Choroidal Melanoma after Vitrectomy and Scleral Buckle for Rhegmatogenous Retinal Detachment

Julie M.ShabtoMBA1Chris S.BergstromMD2Jill R.WellsMD1

doi : 10.1016/j.ophtha.2021.07.029

Buy The Package and View The Article Online

The Association among Blood Pressure, Blood Pressure Medications, and Glaucoma in a Nationwide Electronic Health Records Database

Eric B.LeeBSWendengHuMSKuldevSinghMDSophia Y.WangMD

doi : 10.1016/j.ophtha.2021.10.018

Buy The Package and View The Article Online

High-Density Lipoprotein 3 Cholesterol and Primary Open-Angle Glaucoma: Metabolomics and Mendelian Randomization Analyses

SimonNusinoviciPhD1HengtongLiMS1SahilThakurMD1ManiBaskaranMD1Yih-ChungThamPhD13LeiZhouPhD12CharumathiSabanayagamMD, PhD13TinAungFRCS(Ed), PhD123DavidSilverPhD4QiaoFanPhD5Tien YinWongMD, PhD123JonathanCrowstonMD, PhD13Ching-YuChengMD, PhD123

doi : 10.1016/j.ophtha.2021.09.013

Buy The Package and View The Article Online

Long-Term Follow-up of Epstein Viral Keratitis

AliceMatobaMD1Dan B.JonesMD1GregNettuneMD, MPH2

doi : 10.1016/j.ophtha.2021.07.030

Buy The Package and View The Article Online

Archway Randomized Phase 3 Trial of the Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration

Nancy M.HolekampMD1Peter A.CampochiaroMD2Margaret A.ChangMD, MS3DanielMillerMD, PhD4DantePieramiciMD5Anthony P.AdamisMD6ChristopherBrittainMD6EricaEvansPhD6DerrickKaufmanPhD6Katie F.MaassPhD6ShienalPatelBSc6ShrirangRanadePhD6NatashaSinghPharmD6GiulioBarteselliMD6CarlRegilloMD7all Archway Investigators

doi : 10.1016/j.ophtha.2021.09.016

Buy The Package and View The Article Online

Residual Oil from Hydraulic Fluid Trauma Presenting as Discrete Periorbital Foreign Bodies

Aaron R.KaufmanMD1PeteSetabutrMD1Amy Y.LinMD12

doi : 10.1016/j.ophtha.2021.08.016

Buy The Package and View The Article Online

Three-Year Clinical Trial of Low-Concentration Atropine for Myopia Progression (LAMP) Study: Continued Versus Washout: Phase 3 Report

Jason C.YamFCOphthHK, FRCSEd(Edin)12345Xiu JuanZhangPhD1YuzhouZhangMSc1Yu MengWangPhD1Shu MinTangPhD16Fen FenLiPhD17Ka WaiKamFCOphthHK, FHKAM (Ophthalmology)13Simon T.KoFCOphthHK, FHKAM (Ophthalmology)58Benjamin H.K.YipPhD9Alvin L.YoungFRCSI13Clement C.ThamFCOphthHK, FRCOphth1234Li JiaChenFCOphthHK, PhD134Chi PuiPangDphil14

doi : 10.1016/j.ophtha.2021.10.002

Buy The Package and View The Article Online

Lipemia Retinalis in a Baby with Hyperlipoproteinemia

AnatMaytalMD12NoaEla-DalmanMD12

doi : 10.1016/j.ophtha.2021.07.028

Buy The Package and View The Article Online

Efficacy and Safety of 8 Atropine Concentrations for Myopia Control in Children: A Network Meta-Analysis

AhnulHaMD123Seong JoonKimMD, PhD14Sung RyulShimMPH, PhD5Young KookKimMD14∗Jae HoJungMD, PhD14∗

doi : 10.1016/j.ophtha.2021.10.016

Buy The Package and View The Article Online

Development of Glaucoma after Myopic Optic Disc Change in a Teenage Patient

Eun JiLeeMDTae-WooKimMD

doi : 10.1016/j.ophtha.2021.08.001

Buy The Package and View The Article Online

The Association between Noninfectious Uveitis and Coronavirus Disease 2019 Outcomes: An Analysis of United States Claims-Based Data

D. ClaireMillerMS1YuweiSunMS1Evan M.ChenMD12Benjamin F.ArnoldPhD12Nisha R.AcharyaMD, MS1234

doi : 10.1016/j.ophtha.2021.10.007

Buy The Package and View The Article Online

Incidence of Sympathetic Ophthalmia after Inciting Events: A National Database Study in Japan

YoheiHashimotoMD12HirokiMatsuiPT, MPH2NobuakiMichihataMD, PhD3MihoIshimaruPhD, MPH24HideoYasunagaMD, PhD2MakotoAiharaMD, PhD1ToshikatsuKaburakiMD, PhD1

doi : 10.1016/j.ophtha.2021.09.011

Buy The Package and View The Article Online

Trends in Venture Capital Investments in Ophthalmology Companies (2011–2021)

SanchayGuptaBS12∗NishantUppalBS12∗Enchi K.ChangMD1TrevorFetterMBA2David G.HunterMD, PhD13

doi : 10.1016/j.ophtha.2021.09.024

Buy The Package and View The Article Online

Trends in Remote Retinal Imaging Utilization and Payments in the United States

Sophie C.LeeBS1∗Monica K.LiengPhD12∗SusanAlberPhD3NeesurgMehtaMD1ParisaEmami-NaeiniMD, MPH1GlennYiuMD, PhD14

doi : 10.1016/j.ophtha.2021.10.010

Buy The Package and View The Article Online

Efficacy and Safety of Adalimumab and Infliximab for Noninfectious Uveitis

FeliciaTaiBMSc1ParsaMehraban FarBHSc2PetrosPechlivanoglouPhD34Lauren C.RamsayMSc35Jorge R.GeorgakopoulosMD6BeateSanderRN, PhD3578Larissa A.Derzko-DzulynskyMD, FRCSC91011TinaFelfeliMD359

doi : 10.1016/j.ophtha.2021.09.025

Buy The Package and View The Article Online

Re: Chiang et al.: International Classification of Retinopathy of Prematurity, Third Edition (Ophthalmology. 2021;128:e51–e68)

AnilGangweMD1Raj VardhanAzadMD, FRCS(Ed)2SwapnilParchandMD, DNB1ShashwatBeheraMD, DNB1

doi : 10.1016/j.ophtha.2021.10.021

Buy The Package and View The Article Online

Reply

Michael F.ChiangMD1Graham E.QuinnMD, MSCE2Alastair R.FielderFRCP3R.V. PaulChanMD4BrianFleckMD5of the International Committee for the Classification of Retinopathy of Prematurity

doi : 10.1016/j.ophtha.2021.10.020

Buy The Package and View The Article Online